Slide 1: Welcome: Special Shareholders Meeting
Welcome Special Shareholders Meeting 1
Slide 2: Forward-looking statements
This presentation includes forward-looking statements that are based on certain assumptions and reflect our current expectations. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievement
Slide 3: CompuMed: Two Business Lines leveraging Imaging & Analytics
CompuMed Two Business Lines leveraging Imaging & Analytics § Remote Analytics & Monitoring ECG Services ECG Over-reads Key Benefit: remote access to specialist over-read § Imaging Analytics Skeletal Health Key Benefit: Clinically proven cost effective screening solution 3
Slide 4: Skeletal Health Business
Skeletal Health Business We believe that the market may be: • Transitioning from market evangelism to early adoption stage • OEM distribution is driving transition • Key Opportunity segments are in General Practice, OBGYN, ERs & Orthopedic Practices 4
Slide 5: Skeletal Health Business
Skeletal Health Business We believe that there is an opportunity to accelerate a move of the market to a Standard of Care stage due to certain key trends: • Favorable changes in CMS reimbursements • Linkage between bone health and breast cancer as a women’s health issue • Possible pharmaceutical inv
Slide 6: FFDM Linked Markets
FFDM Linked Markets • Assuming a linkage of new FFD Mammography unit shipments with OsteoGram… • Assuming a modest penetration of FFDM new unit shipments of 2% in year 1 climbing to 20% in year 4… • We can estimate an OsteoGram potential US unit placement opportunity in excess of 1,700 units between
Slide 7: Skeletal Health Products
Skeletal Health Products We believe that the market will require segmentation of product offering: • OsteoGram is a solution in high-volume, tightly integrated workflow environments • We are missing a solution for lower volume, standalone or portable markets • The latter may represent an even larger
Slide 8: Management strategies for our Skeletal Health Business
As a result of these market conditions and trends Management intends to pursue the following strategies for our Skeletal Health Business: 8
Slide 9: Skeletal Health Strategies
Skeletal Health Strategies • Link OsteoGram to FFDM • Seek partnerships with market leaders • Pursue tight integration 9
Slide 10: Skeletal Health Strategies
Skeletal Health Strategies • Position OsteoGram as screening solution • Seek alignment with pharmaceutical industry • Seek integrated role with cDXA providers 10
Slide 11: Skeletal Health Strategies
Skeletal Health Strategies • Deliver a “desktop” solution for stand-alone & retro-fit markets • Seek suitable accretive Acquisition • Expand the technology domain of the company 11
Slide 12: Challenges
Challenges • Market timing • Market fragmentation • Capital Constraints • OEM sell-through & long term commitment • cDXA role evolution • Workflow complexities • Technology obsolescence • Picking the right Partners 12
Slide 13: ECG Services
ECG Services We have been the market leader in Correctional markets, however we believe that: • Our laboratory & systems are capable to handle higher volumes with minimal expansion • High margin market opportunities may exist in Surgical/Mental and Military markets • Minimal QOS changes are required
Slide 14: Surgical Center Case
Surgical Center Case • 150 sites, early implementation in 3 test sites • High QOS Requirement • Less cost sensitive • Requests over-reads for virtually all transmission • Highest revenue-per-site in our network 14
Slide 15: ECG Services
ECG Services We believe that our QOS as well as clinical capabilities are key in expanding the market: • Expansion of CardioGram capabilities to full 7x24 • Automated Digital Workflow • Improved stat overreading with QOS turnaround commitments • Expanded clinical services 15
Slide 16: Management strategies for our ECG business
As a result of these market conditions and trends Management intends to pursue the following strategies for our ECG business: 16
Slide 17: ECG Services Strategies
ECG Services Strategies • Improve QOS • Expand network of Cardiologists • Expand digital workflow • Implement 7x24 operations 17
Slide 18: ECG Services Strategies
ECG Services Strategies • Expand to related institutional markets • Surgical Centers • Mental Hospitals 18
Slide 19: ECG Services Strategies
ECG Services Strategies • Expand into Military & VA Markets • GSA Approvals • Provide vertical solution to specific field requirements across each service 19
Slide 20: Challenges
Challenges • Capital Constraints • Budget Cycles • Aggressive Competition • Price Sensitivity • Increased use of off-shore clinical services • New markets evangelism • Technology partners commitment and Obsolescence • Scalability of laboratory and servers 20
Slide 21: In Summary
In Summary • Strategies should be in place to expand each business line • Goal is to consolidate marketplace around our brand and product offerings and gain a position of market leadership in each one of our business lines • We plan in the near term to invest in driving revenue growth • We expect to